Channel Therapeutics Corporation (CHRO)
AMEX
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
USD ($) | USD ($) | |
Return on Assets (%) | -8941.818 | -9776.159 |
Return on Equity (%) | 132.668 | 145.41 |
Return on Invested Capital (%) | 125.115 | 135.185 |
Operating Margin (%) | N/A | N/A |
Net Profit Margin (%) | N/A | N/A |
Book Value Per Share | -0.371 | -0.608 |
Earnings Per Share | -0.246 | -0.696 |
Cash Per Share | 0.006 | 0.009 |
Working Capital Per Share | -0.371 | -0.608 |
Operating Profit Per Share | N/A | N/A |
EBIT Per Share | -0.246 | -0.696 |
EBITDA Per Share | -0.246 | -0.696 |
Free Cash Flow Per Share | -0.246 | -0.696 |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
Current Ratio | N/A | N/A |
Quick Ratio | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A |
Shares Outstanding | 10M | N/A |
Year End December 30 2023 | Mar 2024 | Jun 2024 |
---|---|---|
USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A |
Return on Assets (%) | N/A | N/A |
Return on Equity (%) | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A |
Operating Margin (%) | N/A | N/A |
Net Profit Margin (%) | N/A | N/A |
Sales Per Share | N/A | N/A |
Book Value Per Share | N/A | N/A |
Earnings Per Share | N/A | N/A |
Cash Per Share | N/A | N/A |
Working Capital Per Share | N/A | N/A |
Operating Profit Per Share | N/A | N/A |
EBIT Per Share | N/A | N/A |
EBITDA Per Share | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A |
Current Ratio | N/A | N/A |
Quick Ratio | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A |
Market Cap | 3.98M |
Price to Earnings Ratio | -0.54 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 41.51 |
Price to Book Ratio | -0.62 |
Dividend Yield | - |
Shares Outstanding | 6.03M |
Average Volume (1 week) | 62.13k |
Average Volume (1 Month) | 167.48k |
52 Week Change | -89.00% |
52 Week High | 6.00 |
52 Week Low | 0.45 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.